Suppr超能文献

酒精性肝病在晚期出现,与非酒精性脂肪性肝病相比进展更快。

Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.

作者信息

Shoreibah Mohamed, Raff Evan, Bloomer Joseph, Kakati Donny, Rasheed Khalid, Kuo Yong-Fang, Singal Ashwani K

机构信息

Division of Gastroenterology and Hepatology.

Department of Internal Medicine, UAB, Birmingham, AL, USA.

出版信息

Ann Hepatol. 2016 Mar-Apr;15(2):183-9. doi: 10.5604/16652681.1193707.

Abstract

BACKGROUND AND OBJECTIVE

Steatohepatitis is a common cause of liver disease due to alcohol (ALD) or non-alcoholic fatty liver disease (NAFLD). We performed this study to compare natural history of ALD and NAFLD.

MATERIAL AND METHODS

Retrospective analysis of ALD or NAFLD patients managed at our center (2007-2011). ALD diagnosed by excluding other liver diseases (except HCV) and alcohol abuse of > 40 g/d in women and > 60 g/d in men for > 5 years. NAFLD diagnosed by excluding other liver diseases and a history of alcohol use of < 10 g/d. Cirrhosis was diagnosed using biopsy for uncertain clinical diagnosis.

RESULTS

Compared to patients with NAFLD (n = 365; mean age 50 yrs; 43% males; 53% diabetic), ALD patients (n = 206; mean age 51 yrs; 68% males; 24% diabetic) presented more often with cirrhosis or complications(46vs. 12%; P< 0.0001) with a higher MELD score (13 ± 7 vs. 8 ± 8; P<0.0001). On logistic regression, ALD diagnosis was associated with presence of cirrhosis by over 4-fold (4.1 [1.8-9.1]) even after excluding 23 patients with concomitant HCV. Over median follow up of about 3 and 4 yrs among ALD and NAFLD patients respectively, ALD patients more frequently developed cirrhosis or its complications including HCC with worse transplant free survival (90 vs. 95%; P = 0.038).

CONCLUSIONS

Compared to NAFLD, ALD patients present at an advanced stage of liver disease with a faster progression on follow-up. Prospective multicenter studies are needed to identify potential barriers to early referral of ALD patients as basis for development of strategies to improve outcome of patients with ALD.

摘要

背景与目的

脂肪性肝炎是酒精性肝病(ALD)或非酒精性脂肪性肝病(NAFLD)导致肝脏疾病的常见病因。我们开展本研究以比较ALD和NAFLD的自然病程。

材料与方法

对在我们中心接受治疗的ALD或NAFLD患者(2007 - 2011年)进行回顾性分析。ALD的诊断是通过排除其他肝脏疾病(除HCV外),且女性每日酒精摄入量>40克、男性每日酒精摄入量>60克,持续超过5年。NAFLD的诊断是通过排除其他肝脏疾病且有每日酒精摄入量<10克的饮酒史。对于临床诊断不明确的情况,通过活检诊断肝硬化。

结果

与NAFLD患者(n = 365;平均年龄50岁;43%为男性;53%患有糖尿病)相比,ALD患者(n = 206;平均年龄51岁;68%为男性;24%患有糖尿病)更常出现肝硬化或并发症(46%对12%;P<0.0001),且终末期肝病模型(MELD)评分更高(13±7对8±8;P<0.0001)。在逻辑回归分析中,即使排除23例合并HCV的患者,ALD诊断与肝硬化的存在仍有超过4倍的关联(4.1[1.8 - 9.1])。在ALD和NAFLD患者中,分别进行约3年和4年的中位随访,ALD患者更频繁地发展为肝硬化或其并发症,包括肝癌,且无移植生存期更差(90%对95%;P = 0.038)。

结论

与NAFLD相比,ALD患者在肝病晚期出现,随访中病情进展更快。需要开展前瞻性多中心研究以确定ALD患者早期转诊的潜在障碍,作为制定改善ALD患者预后策略的基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验